You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

medi5752

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor Trial in Bordeaux (MEDI5752)

Not yet recruiting
  • Advanced Solid Tumor
  • MEDI5752
  • Bordeaux, France
    Institut Bergonie
May 24, 2023

Selected Advanced Solid Tumors Trial in Worldwide (MEDI5752, Pemetrexed, Carboplatin)

Recruiting
  • Selected Advanced Solid Tumors
  • MEDI5752
  • +4 more
  • Detroit, Michigan
  • +40 more
Oct 31, 2022

Gastric Cancer Trial in Worldwide (AZD2936, MEDI5752, FOLFOX)

Recruiting
  • Gastric Cancer
  • Beijing, China
  • +25 more
Jan 18, 2023

Advanced or Metastatic NSCLC Trial in Worldwide (Datopotamab deruxtecan, Durvalumab, Carboplatin)

Recruiting
  • Advanced or Metastatic NSCLC
  • Datopotamab deruxtecan
  • +4 more
  • Santa Ana, California
  • +15 more
Dec 13, 2022

NSCLC Trial in Worldwide (Durvalumab, Oleclumab, Monalizumab)

Recruiting
  • Non-small Cell Lung Cancer
  • Stuart, Florida
  • +61 more
Dec 19, 2022

Metastatic NSCLC (NSCLC) Trial in Worldwide (Durvalumab, Danvatirsen, Oleclumab)

Active, not recruiting
  • Metastatic Non-Small Cell Lung Cancer (NSCLC)
  • Iowa City, Iowa
  • +45 more
Jan 13, 2023

Hepatocellular Carcinoma, Biliary Tract Cancer Trial in Worldwide (MEDI5752, Bevacizumab, Lenvatinib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Biliary Tract Cancer
  • MEDI5752
  • +2 more
  • Birmingham, Alabama
  • +44 more
Mar 17, 2023